Elizabeth Altschuler

438 total citations
17 papers, 391 citations indexed

About

Elizabeth Altschuler is a scholar working on Molecular Biology, Public Health, Environmental and Occupational Health and Toxicology. According to data from OpenAlex, Elizabeth Altschuler has authored 17 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 7 papers in Public Health, Environmental and Occupational Health and 4 papers in Toxicology. Recurrent topics in Elizabeth Altschuler's work include Cancer therapeutics and mechanisms (12 papers), Acute Lymphoblastic Leukemia research (7 papers) and DNA and Nucleic Acid Chemistry (5 papers). Elizabeth Altschuler is often cited by papers focused on Cancer therapeutics and mechanisms (12 papers), Acute Lymphoblastic Leukemia research (7 papers) and DNA and Nucleic Acid Chemistry (5 papers). Elizabeth Altschuler collaborates with scholars based in United States, France and Germany. Elizabeth Altschuler's co-authors include Janice Mayes, Michael Hinds, Leonard A. Zwelling, Karl Deisseroth, Fred D. Ledley, Ruud Jansen, Diana Chan, David Murray, Elise S. Bales and David Farquhar and has published in prestigious journals such as Biochemistry, Biochemical Pharmacology and Mutation research. Fundamental and molecular mechanisms of mutagenesis.

In The Last Decade

Elizabeth Altschuler

17 papers receiving 384 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth Altschuler United States 11 331 147 81 60 49 17 391
James D. Liddil United States 12 253 0.8× 86 0.6× 97 1.2× 54 0.9× 46 0.9× 19 427
Evelien Smitskamp-Wilms Netherlands 9 207 0.6× 114 0.8× 86 1.1× 65 1.1× 34 0.7× 13 370
Judith S. Wolverton United States 10 348 1.1× 266 1.8× 45 0.6× 38 0.6× 13 0.3× 11 457
Judith A. Besserer United States 8 241 0.7× 122 0.8× 95 1.2× 41 0.7× 15 0.3× 10 397
Lars H. Jensen Denmark 16 600 1.8× 240 1.6× 87 1.1× 105 1.8× 16 0.3× 25 721
Joan L. Shillis United States 9 203 0.6× 67 0.5× 173 2.1× 60 1.0× 18 0.4× 13 396
Randall W. Steinkampf United States 9 225 0.7× 159 1.1× 82 1.0× 13 0.2× 34 0.7× 13 385
Dorothy H. Trites United States 11 219 0.7× 140 1.0× 73 0.9× 7 0.1× 30 0.6× 15 378
Maurie Markman United States 8 161 0.5× 134 0.9× 123 1.5× 43 0.7× 17 0.3× 12 434
J. Bruynseels Belgium 9 137 0.4× 57 0.4× 31 0.4× 26 0.4× 52 1.1× 18 405

Countries citing papers authored by Elizabeth Altschuler

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Altschuler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Altschuler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Altschuler more than expected).

Fields of papers citing papers by Elizabeth Altschuler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Altschuler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Altschuler. The network helps show where Elizabeth Altschuler may publish in the future.

Co-authorship network of co-authors of Elizabeth Altschuler

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Altschuler. A scholar is included among the top collaborators of Elizabeth Altschuler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Altschuler. Elizabeth Altschuler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Loflin, Paul T., Elizabeth Altschuler, Daniel Hochhauser, Ian D. Hickson, & Leonard A. Zwelling. (1996). Phorbol ester-induced down-regulation of topoisomerase IIα mRNA in a human erythroleukemia cell line. Biochemical Pharmacology. 52(7). 1065–1072. 6 indexed citations
2.
Coughlin, Susan, R. Robinson, Mark P. Wentland, et al.. (1995). Mechanism of action and antitumor activity of (S)-10-(2,6-dimethyl-4-pyridinyl)-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyridol [1,2,3-de]-[1,4]benzothiazine-6-carboxylic acid (WIN 58161). Biochemical Pharmacology. 50(1). 111–122. 32 indexed citations
3.
Ellis, Amy, Elizabeth Altschuler, Elise S. Bales, et al.. (1994). Phorbol regulation of topoisomerases I and II in human leukemia cells. Biochemical Pharmacology. 47(2). 387–396. 4 indexed citations
4.
5.
Mayes, Janice, et al.. (1993). Further characterization of an amsacrine-resistant line of HL-60 human leukemia cells and its topoisomerase II. Biochemical Pharmacology. 46(4). 699–707. 8 indexed citations
6.
Zwelling, Leonard A., et al.. (1993). Activity of two novel anthracene-9,10-diones against human leukemia cells containing intercalator-sensitive or -resistant forms of topoisomerase II. Biochemical Pharmacology. 46(2). 265–271. 18 indexed citations
7.
Mitchell, Michael, et al.. (1992). Relative activity of structural analogues of amsacrine against human leukemia cell lines containing amsacrine-sensitive or -resistant forms of topoisomerase II: use of computer simulations in new drug development.. PubMed. 52(1). 209–17. 22 indexed citations
8.
Zwelling, Leonard A., Diana Chan, Elizabeth Altschuler, et al.. (1991). Effect of bryostatin 1 on drug-induced, topoisomerase II-mediated DNA cleavage and topoisomerase 11 gene expression in human leukemia cells. Biochemical Pharmacology. 41(5). 829–832. 1 indexed citations
9.
Murray, David, et al.. (1991). Effect of thiols on micronucleus frequency in γ-irradiated mammalian cells. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 247(1). 167–173. 11 indexed citations
10.
Zwelling, Leonard A., Elizabeth Altschuler, Janice Mayes, Michael Hinds, & Diana Chan. (1991). The effect of staurosporine on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells. Cancer Chemotherapy and Pharmacology. 29(1). 48–52. 4 indexed citations
11.
Zwelling, Leonard A., Michael Hinds, Diana Chan, et al.. (1991). Cross-resistance of an amsacrine-resistant human leukemia line to topoisomerase II reactive DNA intercalating agents. Evidence for two topoisomerase II directed drug actions. Biochemistry. 30(16). 4048–4055. 37 indexed citations
12.
Hinds, Michael, Karl Deisseroth, Janice Mayes, et al.. (1991). Identification of a point mutation in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II.. PubMed. 51(17). 4729–31. 126 indexed citations
13.
Zwelling, Leonard A., Elizabeth Altschuler, Abdallah Cherif, & David Farquhar. (1991). N-(5,5-diacetoxypentyl)doxorubicin: a novel anthracycline producing DNA interstrand cross-linking and rapid endonucleolytic cleavage in human leukemia cells.. PubMed. 51(24). 6704–7. 28 indexed citations
14.
15.
Zwelling, Leonard A., Michael Hinds, Diana Chan, et al.. (1990). Phorbol ester effects on topoisomerase II activity and gene expression in HL-60 human leukemia cells with different proclivities toward monocytoid differentiation.. PubMed. 50(22). 7116–22. 33 indexed citations
16.
Murray, David, et al.. (1988). Radioprotection of Cultured Chinese Hamster Ovary Cells by WR-255591. International Journal of Radiation Biology. 54(2). 269–283. 12 indexed citations
17.
Altschuler, Elizabeth, et al.. (1980). Development of an assay for H2-receptor antagonists using isolated fat cells. Journal of Pharmacological Methods. 3(3). 253–266. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by James D. Liddil Breakdown of academic impact, for papers by Evelien Smitskamp-Wilms Breakdown of academic impact, for papers by Judith S. Wolverton Breakdown of academic impact, for papers by Judith A. Besserer Breakdown of academic impact, for papers by Lars H. Jensen Breakdown of academic impact, for papers by Joan L. Shillis Breakdown of academic impact, for papers by Randall W. Steinkampf Breakdown of academic impact, for papers by Dorothy H. Trites Breakdown of academic impact, for papers by Maurie Markman Breakdown of academic impact, for papers by J. Bruynseels
Rankless by CCL
2026